PanKind Australian Pancreatic Cancer Foundation Limited
Tips for Applicants
Researchers interested in pancreatic cancer are encouraged to review Pankind's research strategy and apply for grants as outlined on their 'For researchers' section. The foundation prioritizes early detection breakthroughs and new treatment possibilities. Applicants should align with the mission to triple survival rates by 2030.
Giving Philosophy
PanKind believes in a 'fair fight' against pancreatic cancer, addressing inequities in research and care. Their approach involves driving systemic change by investing in cutting-edge scientific research for early detection and new treatments, providing evidence-based support resources, collaborating for advocacy, and raising national awareness. They operate with urgency, fostering global partnerships to amplify impact and ensure equitable access to life-saving treatments worldwide.
ACNC Financial History
| Year | Grants Given | Revenue | Total Assets | Net Assets |
|---|---|---|---|---|
| FY2023 | $1.6M | $4.3M | $4.4M | $2.6M |
| FY2022 | $1.7M | $3.8M | $4.1M | $2.1M |
| FY2021 | $1.7M | $1.9M | $3.6M | $1.5M |
| FY2020 | $1.5M | $2.2M | $3.5M | $2.6M |
| FY2019 | $200K | $1.1M | $3.8M | $2.0M |
| FY2018 | $1.9M | $1.4M | $4.6M | $1.9M |
| FY2017 | $2.0M | $1.1M | $5.6M | $2.9M |
| 7yr total | $10.6M | Source: ACNC Annual Information Statements | ||
Programs & Opportunities (5)
5 open · sorted by deadline · last checked 27 April 2026 (49 days ago)
Marianne Allan Pancreatic Research Grant
In 2025, an Early Detection Grant was named the Marianne Allan Pancreatic Research Grant in honour of Marianne Allan, dedicated to helping improve outcomes through detecting pancreatic cancer earlier.
Research Grants
Research projects focusing on early detection, new treatments, tumour microenvironment, and clinical management of pancreatic cancer
New Treatment Innovation Grant
This grant supports early-stage research to develop new treatments, diagnostics, or quality-of-care improvements for pancreatic cancer. It funds innovative ideas that have the potential to impact treatment or diagnostics, even without extensive preliminary supporting data.
New Treatment Accelerator Grant
This grant funds advanced research to fast-track new treatments from the lab to clinical application, driving real-world impact. It contributes to advancing the translation of promising therapies to clinical studies or practice.
Early Detection Innovation Grant
This grant funds innovative research to improve early detection and diagnosis of pancreatic cancer by supporting feasibility and proof-of-concept studies. It supports established and/or early career Australian researchers to develop preliminary data and attract additional funding.
Program History (1)
Year-specific program memory with visible provenance. This is the bridge between open opportunities and recurring portfolio strands.
Research Grants
Research projects focusing on early detection, new treatments, tumour microenvironment, and clinical management of pancreatic cancer